Course content

Combination of lectures, discussion rounds, and group work on thematic case studies. Topics: Adjuvant systems, such as aluminum salts, oil-in-water emulsions, water-in-Oil emulsions, liposomes, PLGA particles, virosomes, QS21, TLR ligands) and preclinical and clinical development of adjuvanted vaccines

Learning Outcomes 

Good understanding of the different adjuvant systems and of the challenges of preclinical and clinical development of adjuvanted vaccines.

M3  Adjuvants and Vaccine Formulation

Course Goals 

The course provides an overview of State-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines.

Timeline 

Application Deadline:  

Postponed*

Course Dates:

Q1 2021 (4 days)

Contact 

Maria Lawrenz

maria.lawrenz@vformulation.org

* Due to COVID19 related delays call and training modules' schedule may be subject to change.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative